disseminated tuberculosis
Recently Published Documents


TOTAL DOCUMENTS

590
(FIVE YEARS 112)

H-INDEX

23
(FIVE YEARS 2)

2023 ◽  
Vol 20 (1) ◽  
Author(s):  
Aradhita Maheshwari ◽  
Ira Shah


2023 ◽  
Vol 20 (2) ◽  
Author(s):  
Tsering Yangchen ◽  
Ira Shah


2021 ◽  
pp. 004947552110531
Author(s):  
Laxmikant Ramkumarsingh Tomar ◽  
Neha Pandita ◽  
Sakshi Arya ◽  
CS Agrawal

Neurological side-effects of linezolid manifesting as a posterior reversible leuco-encephalopathy syndrome (PRES) is rare. Early identification of this offending drug might reverse this catastrophic event. We report a 45-year-old female, who was diagnosed as a case of disseminated tuberculosis and was treated with antitubercular drugs (ATT), but later developed ATT-induced hepatitis. She was then put on modified ATT (moxifloxacin, terizidone, and linezolid). In the next two days she developed an altered sensorium. Brain imaging was suggestive of PRES. Linezolid was withdrawn, following which she showed an excellent clinical and radiological recovery.





Medicine ◽  
2021 ◽  
Vol 100 (47) ◽  
pp. e27886
Author(s):  
Qi Zhou ◽  
MiaoXin Zhang


Author(s):  
Martins Ehizode Emuze ◽  
Arinola Esan ◽  
Oladotun Olalusi ◽  
Omolade O Adegoke ◽  
Temitope E Ogunsanya ◽  
...  


Author(s):  
Sharon Weinberg ◽  
Ahsan Mughal

This case highlights the importance of differentiating between Crohn’s disease and intestinal tuberculosis. The rates of misdiagnosis of Crohn’s disease and intestinal tuberculosis range from 50% to 70% because of their non-specific and clinically similar manifestations.If intestinal tuberculosis is misdiagnosed as Crohn’s disease, use of immunomodulatory drugs commonly used for Crohn’s disease can increase the risk of disseminated tuberculosis. Here we present a case highlighting the clinical similarity between these two distinct medical conditions and suggest how a similar scenario can be approached, which can help to differentiate between the two otherwise very similar conditions.



2021 ◽  
Vol 15 (1) ◽  
Author(s):  
Mahdi Khatuni ◽  
Marziyeh Ghalamkari ◽  
Fereshteh Ameli ◽  
Habibeh Yekehtaz

Abstract Background Primary myelofibrosis is a rare myeloproliferative disorder in middle-aged and old adults and should be distinguished from secondary and reactive causes of bone marrow fibrosis because, in reactive fibrosis, treatment approaches depend on the underlying etiology. Case presentation Here we report the case of a middle-aged Iranian man who was diagnosed and treated as primary myelofibrosis at presentation, and whose final diagnosis was disseminated tuberculosis with reactive bone marrow fibrosis. Conclusions It is prudent to evaluate the potential causes of myelofibrosis in any patient with the diagnosis primary myelofibrosis. Tuberculosis can be an important etiology of bone marrow fibrosis, especially in endemic areas.



Sign in / Sign up

Export Citation Format

Share Document